annual CAPEX:
$182.00K-$826.00K(-81.94%)Summary
- As of today (May 29, 2025), ABUS annual capital expenditures is $182.00 thousand, with the most recent change of -$826.00 thousand (-81.94%) on December 31, 2024.
- During the last 3 years, ABUS annual CAPEX has fallen by -$627.00 thousand (-77.50%).
- ABUS annual CAPEX is now -97.49% below its all-time high of $7.26 million, reached on December 31, 2017.
Performance
ABUS CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
N/ASummary
- ABUS quarterly capital expenditures is not available.
Performance
ABUS quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
TTM CAPEX:
N/ASummary
- ABUS TTM capital expenditures is not available.
Performance
ABUS TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
ABUS CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -81.9% | - | - |
| 3 y3 years | -77.5% | - | - |
| 5 y5 years | -69.1% | - | - |
ABUS CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -81.9% | at low | ||||
| 5 y | 5-year | -81.9% | at low | ||||
| alltime | all time | -97.5% | +1113.3% |
ABUS CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $182.00K(-81.9%) | $86.00K(>+9900.0%) | $182.00K(+89.6%) |
| Sep 2024 | - | $0.00(-100.0%) | $96.00K(-25.0%) |
| Jun 2024 | - | $1000.00(-98.9%) | $128.00K(-87.0%) |
| Mar 2024 | - | $95.00K(>+9900.0%) | $986.00K(-2.2%) |
| Dec 2023 | $1.01M(+96.9%) | $0.00(-100.0%) | $1.01M(-11.7%) |
| Sep 2023 | - | $32.00K(-96.3%) | $1.14M(-4.9%) |
| Jun 2023 | - | $859.00K(+634.2%) | $1.20M(+116.8%) |
| Mar 2023 | - | $117.00K(-12.7%) | $554.00K(+8.2%) |
| Dec 2022 | $512.00K(-36.7%) | $134.00K(+47.3%) | $512.00K(+17.4%) |
| Sep 2022 | - | $91.00K(-57.1%) | $436.00K(+19.5%) |
| Jun 2022 | - | $212.00K(+182.7%) | $365.00K(-53.5%) |
| Mar 2022 | - | $75.00K(+29.3%) | $785.00K(-3.0%) |
| Dec 2021 | $809.00K(+253.3%) | $58.00K(+190.0%) | $809.00K(-10.4%) |
| Sep 2021 | - | $20.00K(-96.8%) | $903.00K(+1.0%) |
| Jun 2021 | - | $632.00K(+538.4%) | $894.00K(+172.6%) |
| Mar 2021 | - | $99.00K(-34.9%) | $328.00K(+43.2%) |
| Dec 2020 | $229.00K(-61.1%) | $152.00K(+1281.8%) | $229.00K(+63.6%) |
| Sep 2020 | - | $11.00K(-83.3%) | $140.00K(-63.5%) |
| Jun 2020 | - | $66.00K(+4.8%) | $384.00K(-34.8%) |
| Dec 2019 | $589.00K(-48.2%) | $63.00K(-75.3%) | $589.00K(-21.8%) |
| Sep 2019 | - | $255.00K(+6.3%) | $753.00K(+2.3%) |
| Jun 2019 | - | $240.00K(+674.2%) | $736.00K(-20.1%) |
| Mar 2019 | - | $31.00K(-86.3%) | $921.00K(-19.1%) |
| Dec 2018 | $1.14M(-84.3%) | $227.00K(-4.6%) | $1.14M(+3.5%) |
| Sep 2018 | - | $238.00K(-44.0%) | $1.10M(-21.4%) |
| Jun 2018 | - | $425.00K(+71.4%) | $1.40M(-65.8%) |
| Mar 2018 | - | $248.00K(+31.9%) | $4.09M(-43.7%) |
| Dec 2017 | $7.26M(+81.8%) | $188.00K(-65.0%) | $7.26M(-24.9%) |
| Sep 2017 | - | $537.00K(-82.8%) | $9.68M(+4.0%) |
| Jun 2017 | - | $3.12M(-9.0%) | $9.30M(+30.3%) |
| Mar 2017 | - | $3.42M(+31.7%) | $7.14M(+78.8%) |
| Dec 2016 | $4.00M(+74.7%) | $2.60M(+1456.3%) | $4.00M(+55.4%) |
| Sep 2016 | - | $167.00K(-82.5%) | $2.57M(-14.1%) |
| Jun 2016 | - | $954.00K(+245.7%) | $2.99M(+23.6%) |
| Mar 2016 | - | $276.00K(-76.5%) | $2.42M(+5.9%) |
| Dec 2015 | $2.29M | $1.17M(+99.3%) | $2.29M(+59.3%) |
| Sep 2015 | - | $589.00K(+53.8%) | $1.44M(+43.7%) |
| Jun 2015 | - | $383.00K(+171.6%) | $999.00K(+15.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2015 | - | $141.00K(-56.3%) | $862.00K(-18.4%) |
| Dec 2014 | $1.06M(+45.7%) | $323.00K(+112.5%) | $1.06M(+13.9%) |
| Sep 2014 | - | $152.00K(-38.2%) | $927.00K(+3.6%) |
| Jun 2014 | - | $246.00K(-26.6%) | $895.00K(+4.2%) |
| Mar 2014 | - | $335.00K(+72.7%) | $859.00K(+18.5%) |
| Dec 2013 | $725.00K(+4733.3%) | $194.00K(+61.7%) | $725.00K(+36.0%) |
| Sep 2013 | - | $120.00K(-42.9%) | $533.00K(+28.9%) |
| Jun 2013 | - | $210.00K(+4.5%) | $413.40K(+92.2%) |
| Mar 2013 | - | $201.00K(>+9900.0%) | $215.10K(+1343.6%) |
| Dec 2012 | $15.00K(-75.2%) | $2000.00(+400.0%) | $14.90K(-21.2%) |
| Sep 2012 | - | $400.00(-96.6%) | $18.90K(+29.5%) |
| Jun 2012 | - | $11.70K(+1362.5%) | $14.60K(+239.5%) |
| Mar 2012 | - | $800.00(-86.7%) | $4300.00(-92.9%) |
| Dec 2011 | $60.40K(-92.7%) | $6000.00(-253.8%) | $60.40K(-31.4%) |
| Sep 2011 | - | -$3900.00(-378.6%) | $88.10K(-51.5%) |
| Jun 2011 | - | $1400.00(-97.5%) | $181.60K(-47.5%) |
| Mar 2011 | - | $56.90K(+68.8%) | $345.70K(-58.4%) |
| Dec 2010 | $830.80K(-48.8%) | $33.70K(-62.4%) | $830.90K(-39.7%) |
| Sep 2010 | - | $89.60K(-45.9%) | $1.38M(-12.1%) |
| Jun 2010 | - | $165.50K(-69.5%) | $1.57M(+2.3%) |
| Mar 2010 | - | $542.10K(-6.6%) | $1.53M(-5.6%) |
| Dec 2009 | $1.62M(+68.0%) | $580.30K(+108.4%) | $1.62M(+28.7%) |
| Sep 2009 | - | $278.50K(+113.1%) | $1.26M(+3.6%) |
| Jun 2009 | - | $130.70K(-79.4%) | $1.22M(-12.8%) |
| Mar 2009 | - | $633.50K(+190.3%) | $1.39M(+44.3%) |
| Dec 2008 | $966.40K(-29.1%) | $218.20K(-6.9%) | $966.40K(+29.2%) |
| Sep 2008 | - | $234.40K(-24.1%) | $748.20K(+45.6%) |
| Jun 2008 | - | $308.70K(+50.5%) | $513.80K(+150.5%) |
| Mar 2008 | - | $205.10K | $205.10K |
| Dec 2007 | $1.36M(+1337.2%) | - | - |
| Dec 2006 | $94.90K(+110.9%) | - | - |
| Dec 2005 | $45.00K(-99.4%) | - | - |
| Dec 2004 | $7.15M(+807.6%) | - | - |
| Dec 2003 | $787.70K(-59.6%) | - | - |
| Dec 2002 | $1.95M(+107.2%) | - | - |
| Dec 2001 | $941.60K(+362.5%) | - | - |
| Dec 2000 | $203.60K(-32.3%) | - | - |
| Dec 1999 | $300.60K(-90.7%) | - | - |
| Dec 1998 | $3.22M | - | - |
FAQ
- What is Arbutus Biopharma annual capital expenditures?
- What is the all time high annual CAPEX for Arbutus Biopharma?
- What is Arbutus Biopharma annual CAPEX year-on-year change?
- What is the all time high quarterly CAPEX for Arbutus Biopharma?
- What is the all time high TTM CAPEX for Arbutus Biopharma?
What is Arbutus Biopharma annual capital expenditures?
The current annual CAPEX of ABUS is $182.00K
What is the all time high annual CAPEX for Arbutus Biopharma?
Arbutus Biopharma all-time high annual capital expenditures is $7.26M
What is Arbutus Biopharma annual CAPEX year-on-year change?
Over the past year, ABUS annual capital expenditures has changed by -$826.00K (-81.94%)
What is the all time high quarterly CAPEX for Arbutus Biopharma?
Arbutus Biopharma all-time high quarterly capital expenditures is $3.42M
What is the all time high TTM CAPEX for Arbutus Biopharma?
Arbutus Biopharma all-time high TTM capital expenditures is $9.68M